Associated Papers
Genetics of ischemic stroke functional outcome.
Carnwath TP et al.
Journal of Neurology, 2024
The Role of Single-Nucleotide Polymorphisms in Cholangiocarcinoma: A Systematic Review.
Wang G et al.
Cancers, 2022
Genetic Modifiers of Duchenne Muscular Dystrophy in Chinese Patients.
Chen M et al.
Frontiers in Neurology, 2020
Genetic association analysis of Osteopontin and Matrix Gla Protein genes polymorphisms with primary knee osteoarthritis in Mexican population.
Borgonio-Cuadra VM et al.
Clinical Rheumatology, 2019
Osteopontin splice variants and polymorphisms in cancer progression and prognosis.
Briones-Orta MA et al.
Biochimica Et Biophysica Acta. Reviews on Cancer, 2017
Osteopontin, Bone Morphogenetic Protein-4, and Vitamin D Receptor Gene Polymorphisms in the Susceptibility and Clinical Severity of Spinal Tuberculosis.
Wang G et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 2017
Association between promoter polymorphisms of OPN gene and cancer risk: a meta-analysis.
Liu J et al.
Oncotargets and Therapy, 2016
Association of OPN rs11730582 polymorphism with cancer risk: a meta-analysis.
He L et al.
Oncotargets and Therapy, 2016
Secreted Phosphoprotein 1 Promoter Genetic Variants Are Associated with the Response to Pegylated Interferon α Plus Ribavirin Combination Therapy in Egyptian Patients with Chronic Hepatitis C Virus Infection.
Ali FT et al.
Gut and Liver, 2015
Association between Osteopontin Promoter Gene Polymorphisms and Haplotypes with Risk of Diabetic Nephropathy.
Cheema BS et al.
Journal of Clinical Medicine, 2015
Lessons and implications from association studies and post-GWAS analyses of cervical cancer.
Chen D et al.
Trends in Genetics : Tig, 2015
The OPN gene polymorphism confers the susceptibility and response to Ara-C based chemotherapy in Chinese AML patients.
Zhang R et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 2015
Associations between the Genetic Polymorphisms of Osteopontin Promoter and Susceptibility to Cancer in Chinese Population: A Meta-Analysis.
Liu Y et al.
Plos One, 2015
Association of osteopontin polymorphism with cancer risk: a meta-analysis.
Yang G et al.
International Journal of Clinical and Experimental Medicine, 2015
Serum osteopontin, but not OPN gene polymorphism, is associated with LVH in essential hypertensive patients.
Hou X et al.
Journal of Molecular Medicine (berlin, Germany), 2014
Association of osteopontin polymorphisms with nasopharyngeal carcinoma risk.
Wang J et al.
Human Immunology, 2014
OPN polymorphism is associated with the susceptibility to cervical spondylotic myelopathy and its outcome after anterior cervical corpectomy and fusion.
Wu J et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 2014
OPN Polymorphism Is Related to the Chemotherapy Response and Prognosis in Advanced NSCLC.
Hao Y et al.
International Journal of Genomics, 2014
Polymorphism -433 C>T of the Osteopontin gene is associated with the susceptibility to develop gliomas and their prognosis in a Chinese cohort.
Shen Z et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 2014
An osteopontin promoter polymorphism is associated with aggressiveness in breast cancer.
Ramchandani D et al.
Oncology Reports, 2013
OPN gene polymorphisms influence the risk of knee OA and OPN levels in synovial fluid in a Chinese population.
Jiang Y et al.
Arthritis Research & Therapy, 2013
OPN -443C>T genetic polymorphism and tumor OPN expression are associated with the risk and clinical features of papillary thyroid cancer in a Chinese cohort.
Mu G et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 2013
OPN gene polymorphism and the serum OPN levels confer the susceptibility and prognosis of ischemic stroke in Chinese patients.
Jing M et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 2013
SPP1 promoter polymorphisms and glioma risk in a Chinese Han population.
Chen J et al.
Journal of Human Genetics, 2010
Genetic variation in osteopontin gene is associated with susceptibility to sarcoidosis in Slovenian population.
Maver A et al.
Disease Markers, 2009
SPP1 promoter polymorphisms: identification of the first modifier gene for pseudoxanthoma elasticum.
Hendig D et al.
Clinical Chemistry, 2007
Polymorphisms in the osteopontin promoter affect its transcriptional activity.
Giacopelli F et al.
Physiological Genomics, 2004